Prudential Financial’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.99M | Sell |
|
|||||
|
2025
Q2 | $3.85M | Sell |
|
|||||
|
2025
Q1 | $4.42M | Sell |
|
|||||
|
2024
Q4 | $7.39M | Buy |
|
|||||
|
2024
Q3 | $6.78M | Buy |
|
|||||
|
2024
Q2 | $100K | Buy |
|
|||||
|
2024
Q1 | $73.5K | Hold |
|
|||||
|
2023
Q4 | $86.6K | Buy |
|
|||||
|
2023
Q3 | $99.2K | Hold |
|
|||||
|
2023
Q2 | $98.6K | Hold |
|
|||||
|
2023
Q1 | $152K | Sell |
|
|||||
|
2022
Q4 | $161K | Sell |
|
|||||
|
2022
Q3 | $155K | Buy |
|
|||||
|
2022
Q2 | $130K | Hold |
|
|||||
|
2022
Q1 | $228K | Buy |
|
|||||
|
2021
Q4 | $192K | Sell |
|
|||||
|
2021
Q3 | $217K | Buy |
|
|||||
|
2021
Q2 | $219K | Buy |
|
|||||
|
2021
Q1 | $139K | Sell |
|
|||||
|
2020
Q4 | $108K | Buy |
|
|||||
|
2020
Q3 | $43K | Buy |
|
|||||
|
2020
Q2 | $56K | Buy |
|
|||||
|
2020
Q1 | $22K | Buy |
|
|||||
|
2019
Q4 | $38K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $40K | Buy |
|
|||||
|
2019
Q1 | $85K | Hold |
|
|||||
|
2018
Q4 | $84K | Sell |
|
|||||
|
2018
Q3 | $82K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $168K | Buy |
|